Relative potency of varenicline or fluvoxamine to reduce responding for ethanol versus food depends on the presence or absence of concurrently earned food

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 3, 2014, Pages 860-870

  Ginsburg, Brett C ^a   Lamb, Richard J ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

Alcohol; Operant; Pharmacotherapy; Selectivity

Indexed keywords

ALCOHOL; DRINKING WATER; FLUVOXAMINE MALEATE; SUCROSE; VARENICLINE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FOOD AVAILABILITY; FOOD INTAKE; FOOD PREFERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; STIMULUS RESPONSE;

ALCOHOL DRINKING; ANIMALS; BENZAZEPINES; CONDITIONING, OPERANT; EATING; ETHANOL; FLUVOXAMINE; MALE; NICOTINIC AGONISTS; QUINOXALINES; RATS; RATS, INBRED LEW; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 84896316734     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12285     Document Type: Article

References (30)

1. Angelone SM, Bellini L, Bella DD, Catalano M (1998) Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics. Alcohol Alcohol 33:151-156.
2. Beardsley PM, Lemaire GA, Meisch RA (1993) Persistence of ethanol self-administration as a function of interreinforcer interval and concentration. Drug Alcohol Depend 34:71-81.
3. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 57:289-300.
4. Cahill K, Stead LF, Lancaster T (2011) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (2):CD006103.
5. Chick J, Aschauer H, Hornik K (2004) Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology. Drug Alcohol Depend 74:61-70.
6. Cohen SL (1998) Behavioral momentum: the effects of the temporal separation of rates of reinforcement. J Exp Anal Behav 69:29-47.
7. Ginsburg BC, Koek W, Javors MA, Lamb RJ (2005) Effects of fluvoxamine on a multiple schedule of ethanol- and food-maintained behavior in two rat strains. Psychopharmacology (Berl) 180:249-257.
8. Ginsburg BC, Lamb RJ (2006) Fluvoxamine effects on concurrent ethanol- and food-maintained behaviors. Exp Clin Psychopharmacol 14:483-492.
9. Ginsburg BC, Lamb RJ (2008) Reinforcement magnitude modulation of rate-dependent effects of fluvoxamine and desipramine in the rat. Behav Pharmacol 19:829-835.
10. Ginsburg BC, Lamb RJ (2013) Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure. Alcohol Clin Exp Res 37:1228-1233.
11. Ginsburg BC, Pinkston JW, Lamb RJ (2012) The potency of fluvoxamine to reduce ethanol self-administration decreases with concurrent availability of food. Behav Pharmacol 23:134-142.
12. Harper DN (1999) Behavioral resistance to haloperidol and clozapine. Behav Process 46:1-13.
13. Kamens HM, Andersen J, Picciotto MR (2010a) Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl) 208:613-626.
14. Kamens HM, Andersen J, Picciotto MR (2010b) The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. Alcohol Clin Exp Res 34:2053-2060.
15. Kelleher RT, Morse WH (1968) Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol 60:1-56.
16. Lamb RJ, Ginsburg BC (2005) Fluvoxamine and desipramine on fixed-ratio responding: effects of reinforcement magnitude. Behav Pharmacol 16:573-578.
17. Lamb RJ, Ginsburg BC (2008) Reinforcement magnitude modulates the rate-dependent effects of fluvoxamine and desipramine on fixed-interval responding in the pigeon. Behav Pharmacol 19:51-60.
18. Lamb RJ, Järbe TU (2001) Effects of fluvoxamine on ethanol-reinforced behavior in the rat. J Pharmacol Exp Ther 297:1001-1009.
19. Litten RZ, Ryan ML, Fertig JB, Falk DE, Johnson B, Dunn KE, Green AI, Pettinati HM, Ciraulo DA, Sarid-Segal O, Kampman K, Brunette MF, Strain EC, Tiouririne NA, Ransom J, Scott C, Stout R; for the NCIG (National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group) Study Group (2013) A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J Addict Med 7:277-286.
20. McKee SA, Harrison ELR, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E (2009) Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 66:185-190.
21. Mechner F (1959) A notation system for the description of behavioral procedures. J Exp Anal Behav 2:133-150.
22. Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801-805.
23. Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL (2012) Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology (Berl) 223:299-306.
24. Nevin JA, Grace RC (2000) Behavioral momentum and the law of effect. Behav Brain Sci 23:73-90; discussion 90-130.
25. Pettinati HM (2001) The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes. J Clin Psychiatry 62(Suppl 20):26-31.
26. R Development Core Team (2012) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna.
27. Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, Palmer J, Bonaventure P, Carruthers NI, Lovenberg TW, Boggs J, Galici R (2011) Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology (Berl) 215:191-203.
28. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA 104:12518-12523.
29. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M (2009) The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. Behav Pharmacol 20:474-483.
30. Wouda JA, Riga D, De Vries W, Stegeman M, van Mourik Y, Schetters D, Schoffelmeer ANM, Pattij T, De Vries TJ (2011) Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control. Psychopharmacology (Berl) 216:267-277.